How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications

被引:54
作者
Capitanio, Umberto [1 ]
Pellucchi, Federico [1 ]
Gallina, Andrea [1 ]
Briganti, Alberto [1 ]
Suardi, Nazareno [1 ]
Salonia, Andrea [1 ]
Abdollah, Firas [1 ]
Di Trapani, Ettore [1 ]
Jeldres, Claudio [2 ]
Cestari, Andrea [1 ]
Karakiewicz, Pierre I. [2 ]
Montorsi, Francesco [1 ]
机构
[1] Univ Vita Salute, Hosp San Raffaele, Dept Urol, Milan, Italy
[2] Univ Montreal, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
关键词
prostate cancer; lymphadenectomy; lymphocoele; lymphorrhoea; LYMPH-NODE DISSECTION; MOLECULAR-WEIGHT HEPARIN; CANCER; METASTASES; PREVENTION; OCTREOTIDE; CARCINOMA; SEROMAS; RISK; MEN;
D O I
10.1111/j.1464-410X.2010.09580.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To identify clinical and pathological variables that may help clinicians in predicting, preventing and managing lymphorrhoea and clinically significant lymphocoeles (CSL), which are reported complications after pelvic lymphadenectomy (PLND) and retropubic radical prostatectomy (RRP). PATIENTS AND METHODS We prospectively analysed 552 consecutive men with prostate cancer who underwent RRP and PLND (2006-2008). All patients had detailed clinical and pathological data prospectively recorded in an electronic database. Drains were removed when the amount of lymph was < 20 mL in the previous 24 h. A CSL was defined as the presence of a symptomatic lymphocoele requiring treatment. Lymphorrhoea was defined as the total amount of lymph drained by the drains until their removal. Univariable and multivariable logistic regression models were used to test the association between all the predictors (age, body mass index, American Society of Anesthesiologists score, prostate volume, clinical stage, number of LNs removed, surgeon, pathological T and N stage) and the presence of CSL. Univariable and multivariable linear regression models were also used to test the association between the available predictors and lymphorrhoea. RESULTS The median (range) number of LNs removed was 20 (1-63). Both linear and logistic multivariable regression analysis showed that the number of removed LNs and age were the only two statistically significant predictors of total amount of lymphorrhoea and CSL after RRP and PLND (both P < 0.01). Specifically, the risk of developing a CSL increased by 5% for every LN removed. Similarly, every year of age increased the risk of having CSL by 5%. The most informative thresholds for predicting CSL were 65 years of age and 20 LNs removed. External iliac lymphadenectomy resulted in a higher associated risk of lymphorrhoea and CLS relative to obturator LN removal (P = 0.001 vs P = 0.1, respectively). CONCLUSIONS There was a positive association between the number of LNs removed and age at RRP with the amount of lymphorrhoea and the risk of developing a CSL. The most informative thresholds in predicting CSL were 65 years of age and 20 LNs removed. External iliac lymphadenectomy resulted in a higher risk of lymphorrhoea and CLS relative to obturator LN removal.
引用
收藏
页码:1095 / 1101
页数:7
相关论文
共 34 条
  • [1] AITKEN DR, 1984, SURG GYNECOL OBSTET, V158, P327
  • [2] Allaf Mohamad E, 2006, Rev Urol, V8, P112
  • [3] Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
    Bader, P
    Burkhard, FC
    Markwalder, R
    Studer, UE
    [J]. JOURNAL OF UROLOGY, 2002, 168 (02) : 514 - 518
  • [4] Pelvic lymphadenectomy in prostate cancer
    Breyer, B. N.
    Greene, K. L.
    Dall'Era, M. A.
    Davies, B. J.
    Kane, C. J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2008, 11 (04) : 320 - 324
  • [5] Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer
    Briganti, Alberto
    Capitanio, Umberto
    Chun, Felix K. -H.
    Gallina, Andrea
    Suardi, Nazareno
    Salonia, Andrea
    Da Pozzo, Luigi F.
    Colombo, Renzo
    Di Girolamo, Valerio
    Bertini, Roberto
    Guazzoni, Giorgio
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Rigatti, Patrizio
    [J]. EUROPEAN UROLOGY, 2008, 54 (04) : 794 - 804
  • [6] Is node-positive prostate cancer always a systemic disease?
    Briganti, Alberto
    Chun, Felix K.
    Karakiewicz, Pierre I.
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2008, 54 (02) : 243 - 246
  • [7] Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer
    Briganti, Alberto
    Chun, Felix K. -H.
    Salonia, Andrea
    Suardi, Nazareno
    Gallina, Andrea
    Da Pozzo, Luigi Filippo
    Roscigno, Marco
    Zanni, Giuseppe
    Valiquette, Luc
    Rigatti, Patrizio
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2006, 50 (05) : 1006 - 1013
  • [8] Pelvic Lymph Node Dissection in Prostate Cancer
    Briganti, Alberto
    Blute, Michael L.
    Eastham, James H.
    Graefen, Markus
    Heidenreich, Axel
    Karnes, Jeffrey R.
    Montorsi, Francesco
    Studer, Urs E.
    [J]. EUROPEAN UROLOGY, 2009, 55 (06) : 1251 - 1265
  • [9] Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: Analysis of predictors for residual disease and biochemical recurrence
    Capitanio, Umberto
    Scattoni, Vincenzo
    Freschi, Massimo
    Briganti, Alberto
    Salonia, Andrea
    Gallina, Andrea
    Colombo, Renzo
    Karakiewicz, Pierre I.
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2008, 54 (01) : 118 - 125
  • [10] Octreotide in the treatment of lymphorrhea after renal transplantation: A preliminary experience
    Capocasale, E.
    Busi, N.
    Valle, R. D.
    Mazzoni, M. P.
    Bignardi, L.
    Maggiore, U.
    Buzio, C.
    Sianesi, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) : 1047 - 1048